Equilibre Biopharmaceuticals

Closed

Equilibre Biopharmaceuticals is a biotech company in New York, United States, founded in 2020. It has raised $31.0M across 2 rounds, most recently a $6.0M Venture Round in December 2022.

Headquarters
New York, New York
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$31.0M
Last Round
$6.0M Venture RoundDec 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. The full record is or through the API.

About

Equilibre Biopharmaceuticals Corp. (also known as Equilibre Neuroscience) was a New York City-based specialty pharmaceutical company founded in 2020 by biotech entrepreneur Sam Waksal, focused on neuroscience and rare-disease drug development. The company licensed assets including a ROCK2 inhibitor program later spun out as Graviton Bioscience. Equilibre appears to have ceased normal operations amid financial distress — its website went offline between August 2023 and January 2024 — and is now the subject of a bankruptcy trustee's lawsuit against its former CEO, reported by STAT News in April 2025.

Summary

It lists 1–10 employees. It has raised $31.0M in total across 2 rounds, most recently a $6.0M Venture Round in Dec 2022. Investors include Third Point Ventures.

Funding History

Data from Indexed.vcUpdated
Venture RoundVenture RoundDec 2022
$6.0M

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Equilibre Biopharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/equilibre-biopharmaceuticals"><img src="https://indexed.vc/api/badge/company/equilibre-biopharmaceuticals" alt="Equilibre Biopharmaceuticals on Indexed.vc" width="260" height="76" /></a>